Literature DB >> 11389058

Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.

L Chen1, N Matsubara, T Yoshino, T Nagasaka, N Hoshizima, Y Shirakawa, Y Naomoto, H Isozaki, K Riabowol, N Tanaka.   

Abstract

Overexpression of ING1, a candidate tumor suppressor gene, efficiently blocks cell growth or induces apoptosis in different experimental systems. ING1 maps to chromosome 13q33-34, and because loss of the terminal region of chromosome 13q has been implicated in esophageal squamous cell cancer (ESCC), we examined ESCC for genetic alterations of ING1. Among 31 informative cases of ESCC, 58.9% of the tumors showed allelic loss at chromosome 13q33-34, and we detected four tumor-specific missense nucleotide changes. These alterations were found within the PHD finger domain and nuclear localization motif of the ING1 and may be functionally involved in the development of ESCC. Because immunohistochemical study revealed that all of the ESCC samples showed loss of ING1 protein expression, genetic or epigenetic alterations that abrogate the normal function of ING1 may contribute to esophageal squamous cell carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389058

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.

Authors:  Li-Sheng Chen; Jian-Bao Wei; Yong-Chun Zhou; Sen Zhang; Jun-Lin Liang; Yun-Fei Cao; Zong-Jiang Tang; Xiao-Long Zhang; Feng Gao
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

3.  Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.

Authors:  Zhi Zhu; Jing Lin; Jian-Hui Qu; Mark-A Feitelson; Can-Rong Ni; Fang-Mei Li; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 4.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

5.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 6.  The role of the tumour suppressor p33 ING1b in human neoplasia.

Authors:  G S Nouman; J J Anderson; J Lunec; B Angus
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

7.  Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.

Authors:  Julieta M Ceruti; María F Ogara; Camino Menéndez; Ignacio Palmero; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2013-03-04       Impact factor: 3.396

Review 8.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 9.  PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks.

Authors:  Lindsey A Baker; C David Allis; Gang G Wang
Journal:  Mutat Res       Date:  2008-07-17       Impact factor: 2.433

10.  Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor.

Authors:  P V Peña; R A Hom; T Hung; H Lin; A J Kuo; R P C Wong; O M Subach; K S Champagne; R Zhao; V V Verkhusha; G Li; O Gozani; T G Kutateladze
Journal:  J Mol Biol       Date:  2008-05-02       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.